Register Now
Course Information

Agenda – Medical Dermatology Therapy Update

Wednesday     Thursday     Friday

Wednesday, April 25, 2018

12:00 pm
Registration, Refreshments, and Exhibits
1:00 pm
Welcoming Remarks
Anthony P. Fernandez, MD, PhD

Update in Rheum/Derm Overlap Diseases

1:10 pm
PPACMAN Update- Combined Rheum/Derm Clinics
Joseph F. Merola, MD, MMSc
1:30 pm
New and Emerging Treatments of Cutaneous Lupus
Joseph F. Merola, MD, MMSc
2:00 pm
New and Emerging Treatments in Dermatomyositis
Victoria P. Werth, MD
2:30 pm
Lupus and Dermatomyositis: Cases with the Masters
Moderator: Leonard H. Calabrese, DO and Anthony P. Fernandez, MD, PhD
Panel: Soumya Chatterjee, MD, MS; Carmen Gota, MD; Joseph F. Merola, MD, MMSc; and Victoria P. Werth, MD
3:15 pm
Refreshment Break and Exhibits
3:45 pm
New and Emerging Treatments in Fibrosing Skin Disorders
Soumya Chatterjee, MD, MS
4:15 pm
New and Emerging Treatments in Cutaneous Vasculitis
Carol Langford, MD
4:45 pm
Fibrosing Skin Disease and Vasculitis: Cases with the Masters
Moderator: Leonard H. Calabrese, DO and Anthony P. Fernandez, MD, PhD
Panel: Soumya Chatterjee, MD, MS; Carol Langford, MD; Neil Korman, MD, PhD; and Christine Warren, MD
5:30 pm
Adjourn

Back to top

Thursday, April 26, 2018

7:15 am
Continental Breakfast and Exhibits
8:00 am
Opening Remarks The History of Cleveland Clinic Dermatology
Anthony P. Fernandez, MD, PhD

Atopic Dermatitis

8:20 am
Pathogenesis Update
Jonathan I. Silverberg, MD, PhD, MPH
8:40 am
Microbiome in Atopic Dermatitis
Christine Warren, MD
9:00 am
UV Phototherapy
Mahwish Irfan, MD
9:20 am
Traditional Topical Treatment Update
Apra Sood, MD
9:40 am
Traditional Systemic Treatment Update
Kenneth Tomecki, MD
10:00 am
Refreshment Break and Exhibits
10:30 am
New and Emerging Topical Treatments
Joan E. Tamburro, DO
10:55 am
New and Emerging Biologic Treatments
Jonathan I. Silverberg, MD, PhD, MPH
11:20 am
New and Emerging Small Molecule Inhibitors
James Fernandez, MD, PhD
11:45 am
Panel Discussion and Questions
James Fernandez, MD, PhD; Mahwish Irfan, MD; Jonathan I. Silverberg, MD, PhD, MPH; Apra Sood, MD; Joan E. Tamburro, DO; Kenneth Tomecki, MD; and Christine Warren, MD
12:00 pm
Lunch Break and Exhibits
1:15 pm

Breakout Sessions

  A) Sarcoidosis and Cutaneous Granulomatous Diseases
Joseph English III, MD, and Misha A. Rosenbach, MD
  B) Mycosis Fungoides/Sezary Syndrome
Kevin Cooper, MD, and Joan Guitart, MD
  C) Hidradenitis Suppurativa and Neutrophilic Dermatoses
Paul Hazen, MD, and Christine Warren, MD
  D) Chronic Urticaria James
Fernandez, MD, PhD, and Apra Sood, MD
2:50 pm
Refreshment Break and Exhibits
3:20 pm

Breakout Sessions

  E) Autoimmune Bullous Diseases
Neil Korman, MD, PhD, and Victoria P. Werth, MD
  F) Alopecia Areata (+/- Vitiligo?)
Shilpi Khetarpal, MD, and Melissa P. Piliang, MD
  G) Hidradenitis Suppurativa and Neutrophilic Dermatoses
Paul Hazen, MD, and Christine Warren, MD
  H) Chronic Urticaria
James Fernandez, MD, PhD, and Apra Sood, MD
5:00 pm
Adjourn

Back to top

Friday, April 27, 2018

7:15 am
Continental Breakfast and Exhibits

Medical Treatment of Cutaneous Malignancies

8:00 am
Burden of Cutaneous Malignancies in the US
Alok Vij, MD
8:20 am
Update in Medical Treatment of Basal Cell Carcinoma
Allison T. Vidimos, MD
8:45 am
Update in Medical Treatment of Squamous Cell Carcinoma
David Adelstein, MD
9:10 am
Update in Medical Treatment of Merkel Cell Carcinoma
Christopher K. Bichakjian, MD
9:35 am
Refreshment Break and Exhibits
10:00 am
Immunohistochemistry in Guiding Systemic Treatment of Advanced Cutaneous Malignancy
Jennifer Ko, MD, PhD
10:25 am
Update in Molecular Diagnostics for Cutaneous Malignancies
Steven Billings, MD
10:45 am
Targeted Treatment of Melanoma: Where Are We and Where Are We Going?
Pauline Funchain, MD
11:30 am
Panel Discussion and Questions
David Adelstein, MD; Christopher K. Bichakjian, MD; Steven Billings, MD; Pauline Funchain, MD; Jennifer Ko, MD, PhD; Allison T. Vidimos, MD; Alok Vij, MD
11:45 am
Lunch Break and Exhibits

Psoriatic Disease

1:00 pm
Psoriasis is a Systemic Disease: Update in Treat-to-Target Goals and Comorbidities
Kevin Cooper, MD
1:25 pm
Update in Traditional Treatments (Topicals, UV phototherapy, Systemics)
Carly Elston, MD
1:50 pm
TNF-Inhibitors: “Classic” Biologics for Psoriatic Disease
Anthony P. Fernandez, MD, PhD
2:15 pm
Refreshment Break and Exhibits
2:45 pm
IL-12/23 Inhibitors and Small Molecule Inhibitors
Neil Korman, MD, PhD
3:10 pm
IL-17 Inhibitors
Laura Korb Ferris, MD, PhD
3:35 pm
Update in Treatment of Psoriasis Arthritis
M. Elaine Husni, MD, MPH
4:00 pm
IL-23 Inhibitors and Other Emerging Psoriasis Treatments
Kenneth B. Gordon, MD
4:25 pm
Panel Discussion and Questions
Kevin Cooper, MD; Carly Elston, MD; Anthony P. Fernandez, MD, PhD; Laura Korb Ferris, MD, PhD; Kenneth B. Gordon, MD; M. Elaine Husni, MD, MPH; and Neil Korman, MD, PhD
4:45 pm
Adjourn